about
AF-MSCs fate can be regulated by culture conditionsSox2 suppression by miR-21 governs human mesenchymal stem cell properties.In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells.Human amniotic fluid stem cells as an attractive tool for clinical applications.Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer.Amniotic fluid and amniotic membrane stem cells: marker discovery.Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure.Platelet-Rich Plasma (PRP) Promotes Fetal Mesenchymal Stem/Stromal Cell Migration and Wound Healing ProcessGAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders
P50
Q36890227-B63F9E1E-2FEF-4A70-A3BB-262A668D264CQ37516478-82765359-7BE3-422E-BDE6-7E44FC660D80Q37568639-1E8736B5-53F6-4D1B-BA2E-99FB5E325E6AQ38058886-EAE8FB48-717A-48E1-9946-C1B17AB49605Q39460127-85E20000-CFF0-43D8-A559-9EB848D2C320Q42196647-5B3C60EE-30EC-4832-B496-07458A2CEFFEQ45180763-A1459A80-1B61-4758-899A-5FD8B2E1E030Q61281064-8F3C40D3-AEBD-4B89-8F26-BCBBBDB3D7EFQ87103748-8A000356-9957-4AFD-B09B-BB06436F569E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
O Trohatou
@ast
O Trohatou
@en
O Trohatou
@es
O Trohatou
@nl
type
label
O Trohatou
@ast
O Trohatou
@en
O Trohatou
@es
O Trohatou
@nl
prefLabel
O Trohatou
@ast
O Trohatou
@en
O Trohatou
@es
O Trohatou
@nl
P106
P108
P31
P496
0000-0001-8012-3163